Alkermes plc diskutieren
Alkermes plc
WKN: A1JKVH / Symbol: ALKS / Name: Alkermes / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
22,60 €
0,89 %
Alkermes plc (NASDAQ: ALKS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target lowered by analysts at Mizuho from $37.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target lowered by analysts at Piper Sandler from $37.00 to $35.00. They now have an "overweight" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Piper Sandler from $35.00 to $39.00. They now have an "overweight" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating. They now have a $25.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $37.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $39.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Jefferies Financial Group Inc. from $42.00 to $50.00. They now have a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Neueste Beiträge
StockNews_com in TechnipFMC PLC diskutieren